Loading…
Optimi Health Corp.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in OPTH.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MODDModular Medical, Inc. | $3.46 | — | 1.2x | — | -247.94% | $28.2M |
| GRDXGridAI Technologies Corp. | $3.96 | — | — | — | — | $28.25M |
| CVMCel Sci Corp | $1.56 | — | 2.5x | — | -252.53% | $27.44M |
| PLRZPolyrizon Ltd. | $13.15 |
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Company description provided by Yahoo Finance.
| — |
| 1.0x |
| — |
| -25.38% |
| $27.39M |
| BYSIBeyondSpring Inc. | $0.67 | — | — | — | — | $27.36M |
| ARAYAccuray Inc | $0.23 | — | 0.6x | — | -80.08% | $26.93M |